Bioresorbable vascular scaffold (BVS) for in-stent chronic total occlusion: Antegrade recanalization and IVUS-guided BVS implantation by radial access

Massimo Medda, Francesco Casilli, Marta Bande, Maria Giulia Latini, Mehdi Ghommidh, Francesca Del Furia, Luigi Inglese

Research output: Contribution to journalArticle


The completely absorbable stents represent one of the latest innovations in the field of interventional cardiology, prospecting the possibility of "vascular repair". In the published trials (ABSORB Cohort A and B, ABSORB EXTEND, and ABSORB II, III and IV) chronic total occlusions (CTOs) were considered an exclusion criteria. More recently the CTO-ABSORB pilot study demonstrated the safety and feasibility of bioresorbable vascular scaffold (BVS) use in case of CTO recanalization. We present the first case, to our knowledge, of in-stent occlusion successfully treated with an everolimus-eluting BVS and discuss its potential advantages in such kind of lesions.

Original languageEnglish
Pages (from-to)63-65
Number of pages3
JournalCardiovascular Revascularization Medicine
Issue number1
Publication statusPublished - Jan 1 2016



  • Bioresorbable vascular scaffold (BVS) implantation
  • Chronic total occlusion (CTO)
  • Intravascular ultrasound (IVUS)
  • Restenosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this